For the quarter ended June 2024, Idexx Laboratories (IDXX) reported revenue of $1 billion, up 6.4% over the same period last year. EPS came in at $2.44, compared to $2.67 in the year-ago quarter. The reported revenue represents a surprise of +0.11% over the Zacks Consensus Estimate of $1 billion. With the consensus EPS estimate being $2.87, the EPS surprise was -14.98%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine thei ...